Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal OTC Drugs market report explains the definition, types, applications, major countries, and major players of the Gastrointestinal OTC Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Purdue Pharma
Boehringer Ingelheim
Teva Pharmaceutical
Procter & Gamble
Reckitt Benckiser
Nestle
Bayer
Sanofi
Abbott
Pfizer
GlaxoSmithKline
Johnson & Johnson
Perrigo
By Type:
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Gastrointestinal OTC Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Gastrointestinal OTC Drugs Outlook to 2028- Original Forecasts
-
2.2 Gastrointestinal OTC Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Gastrointestinal OTC Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Gastrointestinal OTC Drugs Market- Recent Developments
-
6.1 Gastrointestinal OTC Drugs Market News and Developments
-
6.2 Gastrointestinal OTC Drugs Market Deals Landscape
7 Gastrointestinal OTC Drugs Raw Materials and Cost Structure Analysis
-
7.1 Gastrointestinal OTC Drugs Key Raw Materials
-
7.2 Gastrointestinal OTC Drugs Price Trend of Key Raw Materials
-
7.3 Gastrointestinal OTC Drugs Key Suppliers of Raw Materials
-
7.4 Gastrointestinal OTC Drugs Market Concentration Rate of Raw Materials
-
7.5 Gastrointestinal OTC Drugs Cost Structure Analysis
-
7.5.1 Gastrointestinal OTC Drugs Raw Materials Analysis
-
7.5.2 Gastrointestinal OTC Drugs Labor Cost Analysis
-
7.5.3 Gastrointestinal OTC Drugs Manufacturing Expenses Analysis
8 Global Gastrointestinal OTC Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Gastrointestinal OTC Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Gastrointestinal OTC Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Gastrointestinal OTC Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Gastrointestinal OTC Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Laxatives Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-Flatulents Consumption and Growth Rate (2017-2022)
-
9.1.3 Global H2-Antaginists Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anti-Diarrheals Consumption and Growth Rate (2017-2022)
-
9.1.5 Global PPIs Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Anti-Emetics Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastrointestinal OTC Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Gastrointestinal OTC Drugs Market Analysis and Outlook till 2022
-
10.1 Global Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.2.2 Canada Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.2.3 Mexico Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.2 UK Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.3 Spain Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.4 Belgium Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.5 France Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.6 Italy Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.7 Denmark Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.8 Finland Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.9 Norway Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.10 Sweden Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.11 Poland Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.12 Russia Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.3.13 Turkey Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.2 Japan Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.3 India Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.4 South Korea Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.8 Thailand Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.9 Singapore Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.11 Philippines Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.5.2 Colombia Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.5.3 Chile Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.5.4 Argentina Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.5.6 Peru Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.6.3 Oman Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.6.4 Qatar Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.7.2 South Africa Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.7.3 Egypt Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.7.4 Algeria Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Gastrointestinal OTC Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Gastrointestinal OTC Drugs Consumption (2017-2022)
11 Global Gastrointestinal OTC Drugs Competitive Analysis
-
11.1 Purdue Pharma
-
11.1.1 Purdue Pharma Company Details
-
11.1.2 Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Purdue Pharma Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.1.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Boehringer Ingelheim
-
11.2.1 Boehringer Ingelheim Company Details
-
11.2.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.2.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Teva Pharmaceutical
-
11.3.1 Teva Pharmaceutical Company Details
-
11.3.2 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.3.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Procter & Gamble
-
11.4.1 Procter & Gamble Company Details
-
11.4.2 Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Procter & Gamble Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.4.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Reckitt Benckiser
-
11.5.1 Reckitt Benckiser Company Details
-
11.5.2 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Reckitt Benckiser Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.5.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Nestle
-
11.6.1 Nestle Company Details
-
11.6.2 Nestle Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Nestle Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.6.4 Nestle Gastrointestinal OTC Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bayer
-
11.7.1 Bayer Company Details
-
11.7.2 Bayer Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bayer Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.7.4 Bayer Gastrointestinal OTC Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Sanofi
-
11.8.1 Sanofi Company Details
-
11.8.2 Sanofi Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Sanofi Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.8.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Abbott
-
11.9.1 Abbott Company Details
-
11.9.2 Abbott Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Abbott Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.9.4 Abbott Gastrointestinal OTC Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Pfizer
-
11.10.1 Pfizer Company Details
-
11.10.2 Pfizer Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Pfizer Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.10.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 GlaxoSmithKline
-
11.11.1 GlaxoSmithKline Company Details
-
11.11.2 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 GlaxoSmithKline Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.11.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Johnson & Johnson
-
11.12.1 Johnson & Johnson Company Details
-
11.12.2 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Johnson & Johnson Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.12.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Perrigo
-
11.13.1 Perrigo Company Details
-
11.13.2 Perrigo Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Perrigo Gastrointestinal OTC Drugs Main Business and Markets Served
-
11.13.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Gastrointestinal OTC Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Laxatives Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Anti-Flatulents Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global H2-Antaginists Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Anti-Diarrheals Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global PPIs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Anti-Emetics Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Gastrointestinal OTC Drugs Market Analysis and Outlook to 2028
-
13.1 Global Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Gastrointestinal OTC Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Gastrointestinal OTC Drugs
-
Figure of Gastrointestinal OTC Drugs Picture
-
Table Global Gastrointestinal OTC Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Gastrointestinal OTC Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Laxatives Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Flatulents Consumption and Growth Rate (2017-2022)
-
Figure Global H2-Antaginists Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Diarrheals Consumption and Growth Rate (2017-2022)
-
Figure Global PPIs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Emetics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal OTC Drugs Consumption by Country (2017-2022)
-
Table North America Gastrointestinal OTC Drugs Consumption by Country (2017-2022)
-
Figure United States Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Gastrointestinal OTC Drugs Consumption by Country (2017-2022)
-
Figure Germany Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Gastrointestinal OTC Drugs Consumption by Country (2017-2022)
-
Figure China Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Gastrointestinal OTC Drugs Consumption by Country (2017-2022)
-
Figure Brazil Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Gastrointestinal OTC Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Gastrointestinal OTC Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Gastrointestinal OTC Drugs Consumption by Country (2017-2022)
-
Figure Australia Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Gastrointestinal OTC Drugs Consumption and Growth Rate (2017-2022)
-
Table Purdue Pharma Company Details
-
Table Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Pharma Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
-
Table Teva Pharmaceutical Company Details
-
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
-
Table Procter & Gamble Company Details
-
Table Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Procter & Gamble Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
-
Table Reckitt Benckiser Company Details
-
Table Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reckitt Benckiser Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
-
Table Nestle Company Details
-
Table Nestle Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nestle Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Nestle Gastrointestinal OTC Drugs Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Bayer Gastrointestinal OTC Drugs Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Sanofi Gastrointestinal OTC Drugs Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Abbott Gastrointestinal OTC Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Pfizer Gastrointestinal OTC Drugs Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
-
Table Perrigo Company Details
-
Table Perrigo Gastrointestinal OTC Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Perrigo Gastrointestinal OTC Drugs Main Business and Markets Served
-
Table Perrigo Gastrointestinal OTC Drugs Product Portfolio
-
Figure Global Laxatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Flatulents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global H2-Antaginists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Diarrheals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PPIs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Emetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal OTC Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Gastrointestinal OTC Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastrointestinal OTC Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Gastrointestinal OTC Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Gastrointestinal OTC Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Gastrointestinal OTC Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Gastrointestinal OTC Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Gastrointestinal OTC Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Gastrointestinal OTC Drugs Consumption Forecast and Growth Rate (2022-2028)
-
